Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05312151

Organisation Name: COMPASS Pathways

Overal Status: Recruiting

Start Date: July 2022

Last Update: July 21, 2022

Lead Sponsor: COMPASS Pathways

Brief Summary: The Safety and Tolerability of COMP360 in Participants with Post-traumatic Stress Disorder

Conditions:
  • Post Traumatic Stress Disorder


Total execution time in seconds: 0.31450700759888